Patents by Inventor Poppy Firzani Arifin

Poppy Firzani Arifin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CINNAMOMUM BURMANII EXTRACT, EXTRACTION PROCESS AND ITS USE AS PROTON PUMP DOWN-REGULATOR, ENZYME INHIBITOR, AND MUCOPROTECTOR
    Publication number: 20170128513
    Abstract: Extract and/or fraction from Cinnamomum burmanii (DLBS2411) related to its extraction method and its biological activities show activities as antiulcer by conferring mucoprotection and down-regulating H+/KT+ ATPase. Treatment with DLBS2411 decreases the H+/K+ ATPase mRNA level in HEK 293 and gastric parietal cells. In addition, DLBS2411 inhibits activity of H+/K+ ATPase gastric enzyme wherein pH influences this inhibition mechanism. DLBS2411 also has characteristic as antioxidant which is shown by the increase of reducing power as the given dosage increases.
    Type: Application
    Filed: October 19, 2016
    Publication date: May 11, 2017
    Applicant: PT. DEXA MEDICA
    Inventors: POPPY FIRZANI ARIFIN, DEASY DIAH DWI RETNO WULAN, VERONIKA YULIANI, JAMES M. SINAMBELA, RAYMOND R. TJANDRAWINATA
  • Extract of as an antineoplastic, anti-inflammatory and antiangiogenic agent
    Patent number: 9078917
    Abstract: A pharmaceutical dosage form comprising an extract of Phaleria macrocarpa which has antineoplastic, anti-inflammatory, and antiangiogenic activity. Its use as an antineoplastic agent is to inhibit tumour growth. Its use as an anti-inflammatory agent is to relieve inflammation and pain, and also as an antipyretic. Another use is as an antiangiogenic agent to inhibit the growth of new blood vessels to prevent cancer metastasis.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: July 14, 2015
    Assignee: PT. Dexa Medica
    Inventors: Raymond R. Tjandrawinata, Asep Aripin, Poppy Firzani Arifin, Dina Rahmi
  • CINNAMOMUM BURMANII EXTRACT, EXTRACTION PROCESS AND ITS USE AS PROTON PUMP DOWN-REGULATOR, ENZYME INHIBITOR, AND MUCOPROTECTOR
    Publication number: 20140079820
    Abstract: Extract and/or fraction from Cinnamomum burmanii (DLBS2411) related to its extraction method and its biological activities show activities as antiulcer by conferring mucoprotection and down-regulating H+/K+ ATPase. Treatment with DLBS2411 decreases the H+/K+ ATPase mRNA level in HEK 293 and gastric parietal cells. In addition, DLBS2411 inhibits activity of H+/K+ ATPase gastric enzyme wherein pH influences this inhibition mechanism. DLBS2411 also has characteristic as antioxidant which is shown by the increase of reducing power as the given dosage increases.
    Type: Application
    Filed: March 9, 2012
    Publication date: March 20, 2014
    Applicant: PT. DEXA MEDICA
    Inventors: Poppy Firzani Arifin, Deasy Diah Dwi R.W., Veronika Yuliani, James M. Sinambela, Raymond R. Tjandrawinata
  • Isolated compounds from as anti-cancer agents
    Patent number: 8569382
    Abstract: The invention concerns compounds DLBS1425E2.2 and DLBS1425F1 isolated and identified from the extract of the plant Phaleria macrocarpa (Scheff.) Boerl. The invention also relates to the use of said compounds, either as a single active compound or in combination, in a pharmaceutical dosage form that has anti-proliferative activity of cancer cells, and its use relating to female related diseases. Formula (I).
    Type: Grant
    Filed: November 26, 2009
    Date of Patent: October 29, 2013
    Assignee: PT. Dexa Medica
    Inventors: Asep Aripin, Poppy Firzani Arifin, Raymond R. Tjandrawinata
  • ISOLATED COMPOUNDS FROM PHALERIA MACROCARPA AS ANTI-CANCER AGENTS
    Publication number: 20110257112
    Abstract: The invention concerns compounds DLBS1425E2.2 and DLBS1425F1 isolated and identified from the extract of the plant Phaleria macrocarpa (Scheff.) Boerl. The invention also relates to the use of said compounds, either as a single active compound or in combination, in a pharmaceutical dosage form that has anti-proliferative activity of cancer cells, and its use relating to female related diseases. Formula (I).
    Type: Application
    Filed: November 26, 2009
    Publication date: October 20, 2011
    Inventors: Asep Aripin, Poppy Firzani Arifin, Raymond R. Tjandrawinata
  • EXTRACT OF PHALERIA MACROCARPA AS AN ANTINEOPLASTIC, ANTI-INFLAMMATORY AND ANTIANGIOGENIC AGENT
    Publication number: 20110091395
    Abstract: A pharmaceutical dosage form comprising an extract of Phaleria macrocarpa which has antineoplastic, anti-inflammatory, and antiangiogenic activity. Its use as an antineoplastic agent is to inhibit tumour growth. Its use as an anti-inflammatory agent is to relieve inflammation and pain, and also as an antipyretic. Another use is as an antiangiogenic agent to inhibit the growth of new blood vessels to prevent cancer metastasis.
    Type: Application
    Filed: June 8, 2009
    Publication date: April 21, 2011
    Inventors: Raymond Tjandrawinata, Asep Aripin, Poppy Firzani Arifin, Dina Rahmi